Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin

Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Temozolomide after radiotherapy improves glioma survival

Mechanistic studies of DNA repair

Oncology for children: what can be done when resources are scarce?

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates

Targeting T regs in tumours

Integrating multiple omics information in the era of precision oncology

Physical activity may improve prostate cancer prognosis

Inflammatory microenvironment regulates colorectal cancer progression

Chronic lymphocytic leukaemia: Transition to a new era